DRD2 and posterior cortical atrophy: An early study indicated that dopamine could also function as MAO-A substrate to alter its activity, and another study demonstrated that dopamine D2 receptor agonist could enhance the PCa chemotherapy efficacy, suggesting that dopamine may suppress the PCa cells growth39.